Related references
Note: Only part of the references are listed.Genomic Rearrangement Signatures and Clinical Outcomes in High-Grade Serous Ovarian Cancer
R. Tyler Hillman et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Genomic Rearrangement Signatures and Clinical Outcomes in High-Grade Serous Ovarian Cancer
R. Tyler Hillman et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Minimizing inequality in access to precision medicine in breast cancer by real-time population-based molecular analysis in the SCAN-B initiative
L. Ryden et al.
BRITISH JOURNAL OF SURGERY (2018)
Targeting the replication stress response in cancer
Josep V. Forment et al.
PHARMACOLOGY & THERAPEUTICS (2018)
A Dominantly Inherited 5' UTR Variant Causing Methylation-Associated Silencing of BRCA1 as a Cause of Breast and Ovarian Cancer
D. Gareth R. Evans et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2018)
Germline mutations in BRCA1 and BRCA2 incidentally revealed in a biobank research study: experiences from re-contacting mutation carriers and relatives
Martin P. Nilsson et al.
JOURNAL OF COMMUNITY GENETICS (2018)
Analysis of NTRK Alterations in Pan-Cancer Adult and Pediatric Malignancies: Implications for NTRK-Targeted Therapeutics
Ryosuke Okamura et al.
JCO PRECISION ONCOLOGY (2018)
Cyclin E Overexpression Sensitizes Triple-Negative Breast Cancer to Wee1 Kinase Inhibition
Xian Chen et al.
CLINICAL CANCER RESEARCH (2018)
A somatic-mutational process recurrently duplicates germline susceptibility loci and tissue-specific super-enhancers in breast cancers
Dominik Glodzik et al.
NATURE GENETICS (2017)
A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer
Paz Polak et al.
NATURE GENETICS (2017)
HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures
Helen Davies et al.
NATURE MEDICINE (2017)
Identification of pathogenic retrotransposon insertions in cancer predisposition genes
Yaping Qian et al.
CANCER GENETICS (2017)
Whole-Genome Sequencing Reveals Breast Cancers with Mismatch Repair Deficiency
Helen Davies et al.
CANCER RESEARCH (2017)
Ovarian Cancers Harboring Inactivating Mutations in CDK12 Display a Distinct Genomic Instability Pattern Characterized by Large Tandem Duplications
Tatiana Popova et al.
CANCER RESEARCH (2016)
Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer
Melinda L. Telli et al.
CLINICAL CANCER RESEARCH (2016)
Landscape of somatic mutations in 560 breast cancer whole-genome sequences
Serena Nik-Zainal et al.
NATURE (2016)
Biology and Management of Patients With Triple-Negative Breast Cancer
Priyanka Sharma
ONCOLOGIST (2016)
The Sweden Cancerome Analysis Network - Breast (SCAN-B) Initiative: a large-scale multicenter infrastructure towards implementation of breast cancer genomic analyses in the clinical routine
Lao H. Saal et al.
GENOME MEDICINE (2015)
DNA replication stress: Causes, resolution and disease
Abdelghani Mazouzi et al.
EXPERIMENTAL CELL RESEARCH (2014)
Breast cancer-associated missense mutants of the PALB2 WD40 domain, which directly binds RAD51C, RAD51 and BRCA2, disrupt DNA repair
J-Y Park et al.
ONCOGENE (2014)
Genome-driven integrated classification of breast cancer validated in over 7,500 samples
H. Raza Ali et al.
GENOME BIOLOGY (2014)
Mutational Processes Molding the Genomes of 21 Breast Cancers
Serena Nik-Zainal et al.
CELL (2012)
The Life History of 21 Breast Cancers
Serena Nik-Zainal et al.
CELL (2012)
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
Christina Curtis et al.
NATURE (2012)
A refined molecular taxonomy of breast cancer
M. Guedj et al.
ONCOGENE (2012)
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Brian D. Lehmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer
Cornelia Liedtke et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Accurate whole human genome sequencing using reversible terminator chemistry
David R. Bentley et al.
NATURE (2008)
An oncogene-induced DNA damage model for cancer development
Thanos D. Halazonetis et al.
SCIENCE (2008)
Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: The STEEP system
Clifford A. Hudis et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer
Bruce G. Haffty et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Jirina Bartkova et al.
NATURE (2006)
Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
Raffaella Di Micco et al.
NATURE (2006)
Share Paper
